NDC 61841-152 - Theraflex Advance

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 61841-152
Package NDCs from labels: 61841-152-72, 61841-152-12
Manufacturer: Bayer HealthCare LLC.
Effective date: 2026-01-12
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Theraflex™ Advance	Bayer HealthCare LLC.	2026-01-12	HUMAN OTC DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
61841-152-12	Theraflex Advance	1 in 1 CARTON	TABLET	1	7
61841-152-12	Theraflex Advance	120 in 1 BOTTLE	TABLET	120	7
61841-152-72	Theraflex Advance	1 in 1 CARTON	TABLET	1	7
61841-152-72	Theraflex Advance	60 in 1 BOTTLE	TABLET	60	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61841-152	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE LLC.]	6	4 package rows	20240111_8fbde87b-d0d9-4a62-b8a3-9320cbb727a5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CHONDROITIN SULFATE (BOVINE)	ACTIVE INGREDIENT	6IC1M3OG5Z	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
GLUCOSAMINE SULFATE	ACTIVE INGREDIENT	1FW7WLR731	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
IBUPROFEN	ACTIVE INGREDIENT	WK2XYI10QM	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
CONDOLIASE	ACTIVE MOIETY	7SI2UZG934	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
GLUCOSAMINE	ACTIVE MOIETY	N08U5BOQ1K	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
IBUPROFEN	ACTIVE MOIETY	WK2XYI10QM	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE CONSUMER CARE]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 181 of 186 · 3,701 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
childrens ibuprofen	IBUPROFEN	Rite Aid Corporation	af68a4bf-bc49-40c7-812d-035eff474ed9	2020-04-03	Warnings	Exact identifier unii: WK2XYI10QM
JUNIOR STRENGTH ADVIL	IBUPROFEN	Proficient Rx LP	91fc4794-1880-460f-86dd-49d8c1e872bc	2020-03-01	Warnings	Exact identifier unii: WK2XYI10QM
ibuprofen	IBUPROFEN	Proficient Rx LP	6d84ed87-b643-46e2-96d4-2052f41bd936	2020-02-01	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	PURACAP PHARMACEUTICAL LLC	9e86b6e5-5374-4699-a0d1-a4c3d069f262	2020-01-17	Warnings	Exact identifier unii: WK2XYI10QM
childrens ibuprofen	IBUPROFEN	H E B	e7e2b766-6d05-49e2-9e88-72454b857935	2019-12-27	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen 200mg	IBUPROFEN 200MG	Allegiant Health	2e33a153-0a3f-4b88-b193-d63e0b792ccc	2019-12-12	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	PuraCap Pharmaceutical LLC	73eb763e-ce21-4cff-854f-3297f20f1f61	2019-12-10	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	PuraCap Pharmaceutical LLC	40501966-419a-4ccd-b7c9-5581cbe47a97	2019-12-10	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	PuraCap Pharmaceutical LLC	b6e14f73-1f19-4cfa-8858-136a38ee32d0	2019-12-10	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	PuraCap Pharmaceutical LLC	67e09ad5-e010-4aa1-b86e-9b22331bf33b	2019-12-10	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	PuraCap Pharmaceutical LLC	24ef6819-f098-4d01-bfe7-6ffa4aa0e671	2019-12-10	Warnings	Exact identifier unii: WK2XYI10QM
Congestion Relief	IBUPROFEN, PHENYLEPHRINE HCL	Meijer Distribution Inc	84f932b6-0aee-4cf9-b4b9-213560c42c1d	2019-12-05	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	50bab3b2-f710-46ff-96cd-1ec4d4658529	2019-11-22	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	f42506f7-896c-47a9-a4b1-ed72434d7aa0	2019-11-22	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	58bff8bf-5a4e-4390-9c03-e266d31deb6b	2019-11-22	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	daf579dc-91d1-4950-b637-c1a34f5542c5	2019-11-22	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	Sam's West, Inc.	90c301ad-7bbd-4e21-8054-35596b208cd4	2019-11-21	Warnings	Exact identifier unii: WK2XYI10QM
Ibuprofen	IBUPROFEN	Proficient Rx LP	72b32512-05c7-4113-b0cc-de9c97de2abb	2019-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: WK2XYI10QM
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	d701c221-9f68-47ff-b766-2f4f1998649f	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	7f5e6872-4d26-410e-8afe-16a016f9a399	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.